Advertisement

Topics

Leukemia drug enasidenib gains FDA approval for those with IDH2 mutation

05:37 EDT 2 Aug 2017 | SmartBrief

The FDA has approved the use of Celgene and Agios Pharmaceuticals' Idhifa, or enasidenib, as the first treatment for adult pa -More

Original Article: Leukemia drug enasidenib gains FDA approval for those with IDH2 mutation

NEXT ARTICLE

More From BioPortfolio on "Leukemia drug enasidenib gains FDA approval for those with IDH2 mutation"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...